Register for real-time alerts, custom portfolio, and market movers

Get Started

RPHM Reneo Pharmaceuticals Inc

1.67

0.02 (1.21%)

Apr 26 2024 - Closed

Delayed by 15 minutes

Quest upgraded while Teva downgraded at UBS, and VectiveBio scores two new buy initiations in today's analyst action

To read the full story on Seeking Alpha, click here.

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Reneo Pharmaceuticals Charts.

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Reneo Pharmaceuticals Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Reneo Pharmaceuticals Inc News

More Reneo Pharmaceuticals Inc News Articles

Canopus Biopharma (PK)

TideRock Companies (PK)

Cann American (CE)

Ecare Solutions (PK)

Net Savings Link (PK)

Sunshine Biopharma

Atacama Resources (PK)

Seafarer Exploration (PK)

Brookmount Explorations (PK)

Branded Legacy (PK)

BlackStar Enterprise (PK)

Enzolytics (PK)

Delayed Upgrade Clock